共 65 条
[1]
A phase II, multicenter, randomized, double-blind, placebo-controlled trial of the safety and efficacy of velafermin (CG53135-05) administered intravenously as a single dose for the prevention of oral mucositis in patients receiving autologous hematopoietic stem cell transplant (AHSCT)
[J].
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION,
2006, 12 (02)
:21-22
[2]
Blay JY, 1998, BLOOD, V92, P3562
[6]
Cilley Jeffrey, 2006, Haematologica, V91, P114
[9]
DOUGLAS S, 2006, ASH ANN M ABSTR, V108, P3383
[10]
FERNANDEZ HF, 2006, ASBMTICIBMTR TAND M